BioStock

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

Diamyd Medical: a Swedish example of Nobel Prize science in action

2026-01-13 09:33:00

The 2025 Nobel Prize spotlighted peripheral immune tolerance, a principle increasingly shaping new strategies for autoimmune disease. In a conversation with BioStock, Diamyd Medical board member Dr. Karin Rosén shares why this field is now moving from discovery to development – and how the company is applying the science in autoimmune diabetes.

Read the article at biostock.se:
https://biostock.se/en/2026/01/diamyd-medical-ett-svenskt-exempel-pa-nobelprisbelonad-forskning-i-praktiken/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook! 

About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.
BioStock – Connecting Innovation & Capital.

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

BioStock

Prenumeration

Vem äger bolaget?

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden